Affymax, Inc. (NASDAQ:AFFY) and Cerus Corporation (NASDAQ:CERS) Added to Growing Stock Report's NASDAQ Gainers Watch List.

New York, NY -- (SBWIRE) -- 03/14/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Affymax, Inc. (NASDAQ:AFFY) and Cerus Corporation (NASDAQ:CERS).

Affymax, Inc. (NASDAQ:AFFY) a biopharmaceutical company that engages in the development of drugs for the treatment of serious and life-threatening conditions in the United States is currently up (+1.03%) on 1,641,225 shares traded. Affymax, Inc. (NASDAQ:AFFY) is currently up (+33.63%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Affymax, Inc. (NASDAQ:AFFY)

Cerus Corporation (NASDAQ:CERS) a company that together with its subsidiary, Cerus Europe B.V., operates as a biomedical products company that focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety is currently up (+1.67%) on 611,846 shares traded after Cerus announced the pricing of an underwritten public offering of 8,333,333 shares of its common stock, offered at a price to the public of $4.20 per share. Cerus Corporation (NASDAQ:CERS) is currently up (+64.55%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Cerus Corporation (NASDAQ:CERS)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com